Fatal autointoxication with metformin;Een fatale auto-intoxicatie met metformine

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 17, 2007, Pages 981-984

  De Pont, A C J ^a,b   Kerver, E D ^a,b   Jansen, M E P ^b   Bijleveld, Y A ^b   Franssen, E J F ^c   Hoekstra, J B L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Afd Intensive Care Volwassenen C3 327 ^*  (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; LAXATIVE; METFORMIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HEART ARREST; HEMODIALYSIS; HEMOFILTRATION; HUMAN; LACTIC ACIDOSIS; MORTALITY; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; RESUSCITATION; SUICIDE ATTEMPT;

ACIDOSIS; ADULT; DIABETES MELLITUS, TYPE 2; FATAL OUTCOME; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MULTIPLE ORGAN FAILURE; OVERDOSE; SUICIDE, ATTEMPTED;

EID: 34248354716     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rutten GEHM, Grauw WJC de, Nijpels G, Goudswaard AN, Uitewaal PJM, Does FEE van der, et al. NHG-standaard Diabetes mellitus type 2; 2e herziening. Huisarts Wet. 2006;49:137-52.
2. Spiller HA, Quadrani DA. Toxic effects from metformin exposure. Ann Pharmacother. 2004;38:776-80.
3. Von Mach MA, Sauer O, Sacha Weilemann L. Experiences of a poison center with metformin-associated lactic acidosis. Exp Clin Endocrinol Diabetes. 2004;112:187-90.
4. Houwerzijl EJ, Snoek WJ, Haastert M van, Holman ND. Ernstige lactaatacidose bij metforminegebruik bij een patient met contraindicaties voor metformine. Ned Tijdschr Geneeskd. 2000;144:1923-6.
5. Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopeia of modern antidiabetic agents. Diabetes Obes Metab. 2005;7:654-65.
6. Spiller HA, Sawyer TS. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm. 2006;63:929-38.
7. Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102:99-110.
8. Karttunen P, Uusitupa M, Lamminsivu U. The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained-release preparation. Int J Clin Pharmacol Ther Toxicol. 1983;21:31-6.
9. Watson WA, Litovitz TL, Rodgers jr GC, Klein-Schwartz W, Reid N, Youniss J, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23:589-666.
10. Spiller HA. Management of antidiabetic medications in overdose. Drug Saf. 1998;19:411-24.
11. Howlett HC, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf. 1999;20:489-503.
12. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and non-fatal lactic acidosis with metformin use in type 2 diabetes mellitus [Cochrane review]. Cochrane Database Syst Rev. 2006;(1):CD002967.
13. Nyirenda MJ, Sandeep T, Grant I, Price G, McKnight JA. Severe acidosis in patients taking metformin - rapid reversal and survival despite high APACHE score. Diabet Med. 2006;23:432-5.
14. Teale KF, Devine A, Stewart H, Harper NJ. The management of metformin overdose. Anaesthesia. 1998;53:698-701.
15. Guariglia A, Gonzi GL, Regolisti G, Vinci S. Treatment of biguanide-induced lactic acidosis: reproposal of the 'physiological' approach and review of the literature. Ann Ital Med Int. 1994;9:35-9.
16. Heaney D, Majid A, Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant. 1997;12: 1046-7.
17. Lalau JD, Andrejak M, Morinière P, Coevoet B, Debussche X, Westeel PF, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989;27:285-8.
18. Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol. 2002;40:177-80.
19. Panzer U, Kluge S, Kreymann G, Wolf G. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2004;19:2157-8.